Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 120 member C (FAM120C) is a protein-coding gene encoding a putative transmembrane protein, implicated primarily in neurodevelopment. Mutations and deletions involving FAM120C are associated with intellectual disability and autism spectrum disorder, indicating a possible functional role in brain development and synaptic signaling. FAM120C is enriched in brain tissues such as the cortex and cerebellum, and its expression pattern resembles that of FMR1, a gene implicated in Fragile X syndrome. FAM120C encodes an RNA-binding protein, may interact within the FMRP network, and has also been reported as part of a prognostic immune-related RNA-binding protein gene set in head and neck squamous cell carcinoma. There is currently no evidence that FAM120C is a direct therapeutic target, nor are there known drugs interacting with it[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 120 member C (FAM120C).